CIK 0001815442
- Large accelerated filer
Kymera Therapeutics, Inc.
Sign in to watch- Ticker
- KYMR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812992166
- Phone
- +1 857-285-5314
- Business address
- 500 NORTH BEACON STREET, 4TH FLOOR, WATERTOWN, MA, 02472
- Former names
- Kymera Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,158,214
- in 2 filings, $3.4M under 10b5-1 plans
Net −$4,158,214. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 68 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-11 | BVF PARTNERS L P/IL Director | Purchase | +10,961 | $29.89 | $328K | 2,491,703 |
| 2023-01-11 | BVF PARTNERS L P/IL Director | Purchase | +11,149 | $29.89 | $333K | 1,872,439 |
| 2023-01-03 | Chiniara Ellen Chief Legal Officer | Grant or award | +37,500 | 37,500 | ||
| 2023-01-03 | Chiniara Ellen Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +225,000 | 225,000 | ||
| 2022-12-15 | Booth Bruce Director | Sale | −2,561 | $30.00 | $77K | 5,066,925 |
| 2022-12-15 | Booth Bruce Director | Sale | −717 | $30.00 | $22K | 917,811 |
| 2022-12-15 | Atlas Venture Fund X, L.P. 10% owner | Sale | −2,561 | $30.00 | $77K | 5,066,925 |
| 2022-12-15 | Atlas Venture Fund X, L.P. 10% owner | Sale | −717 | $30.00 | $22K | 917,811 |
| 2022-12-14 | Booth Bruce Director | Sale | −112,819 | $30.28 | $3.4M | 5,252,744 |
| 2022-12-14 | Booth Bruce Director | Sale | −101,189 | $31.44 | $3.2M | 5,151,555 |
| 2022-12-14 | Booth Bruce Director | Sale | −54,737 | $32.33 | $1.8M | 5,096,818 |
| 2022-12-14 | Booth Bruce Director | Sale | −13,997 | $33.34 | $467K | 5,082,821 |
| 2022-12-14 | Booth Bruce Director | Sale | −13,335 | $34.02 | $454K | 5,069,486 |
| 2022-12-14 | Booth Bruce Director | Sale | −31,584 | $30.28 | $956K | 969,833 |
| 2022-12-14 | Booth Bruce Director | Sale | −28,329 | $31.44 | $891K | 941,504 |
| 2022-12-14 | Booth Bruce Director | Sale | −15,324 | $32.33 | $495K | 926,180 |
| 2022-12-14 | Booth Bruce Director | Sale | −3,919 | $33.34 | $131K | 922,261 |
| 2022-12-14 | Booth Bruce Director | Sale | −3,733 | $34.02 | $127K | 918,528 |
| 2022-12-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −112,819 | $30.28 | $3.4M | 5,252,744 |
| 2022-12-14 | Atlas Venture Fund X, L.P. 10% owner | Sale | −101,189 | $31.44 | $3.2M | 5,151,555 |
Page 34 of 41 · 810 trades